Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Thrombus Treatment Companies

The treatment of thrombus (blood clot) involves a range of medications, interventions, and therapies aimed at preventing the clot from growing, breaking loose, or causing complications such as deep vein thrombosis (DVT) or pulmonary embolism. Several pharmaceutical companies develop and manufacture medications for thrombus treatment.

Thrombus Treatment Key Companies Latest Thrombus Treatment Companies Update

June 2023: The Lightning Bolt 7 technology, developed by Penumbra, Inc. PEN, is now available. It is used to quickly remove blood clots using modulated aspiration. Penumbra's latest innovation is a computer-assisted thrombectomy service that uses cutting-edge imaging and AI in conjunction with minimally invasive tools to treat vascular disorders including stroke. New aspiration technology and an enhanced microprocessor algorithm enable Lightning Bolt 7 technology to differentiate between a blood clot and normal blood flow. Modulated aspiration at the catheter's tip facilitates rapid and thorough clot removal. The technology is meant to provide a safety profile that, when coupled with the speed and efficiency of clot removal, will encourage an endovascular-first strategy prior to open surgery for a wider variety of situations.

May 2023: Asundexian, an experimental medication developed by Bayer, was recently awarded Fast Track Designation by the U.S. FDA for the treatment and prevention of stroke and systemic embolism in persons with atrial fibrillation (AF). This comes after asundexian received its first U.S. FDA Fast Track Designation in 2022, this time for the treatment of patients who have had a non-cardioembolic ischemic stroke. Blood coagulation involves the conversion of a protein called Factor XI into an active enzyme called Factor XIa. By selectively inhibiting FXIa, we can prevent the production of pathological thrombi while sparing the recovery of physiological arterial wall damage. The antithrombotic drug asundexian is now being studied for its potential as an enhanced therapy option in thrombosis prevention.

List of Thrombus Treatment Key companies in the market

Teva Pharmaceutical Industries Ltd. (Israel)

AngioDynamics Inc. (US)

Bristol-Myers Squibb Company (US)

Pfizer Inc. (US)

Johnson & Johnson Services Inc. (US)

Sanofi S.A. (France)

Daiichi Sankyo Company, Limited (Tokyo)

Boehringer Ingelheim International GmbH (Germany)

Aspen Pharmacare Holdings Limited (US)

Bayer AG (Germany)

Thrombus Treatment Market Highlights:

Thrombus Treatment Market Size

Thrombus Treatment Market Trends

Thrombus Treatment Market Analysis

Thrombus Treatment Market Share

Thrombus Treatment Market Highlights:

Thrombus Treatment Market Trends

Thrombus Treatment Market Analysis

Thrombus Treatment Market Share

Thrombus Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.